Virginia Retirement Systems’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $885K | Buy |
43,000
+1,900
| +5% | +$39.1K | 0.01% | 543 |
|
|
2023
Q2 | $1.93M | Buy |
41,100
+8,400
| +26% | +$395K | 0.02% | 363 |
|
|
2023
Q1 | $1.37M | Buy |
32,700
+1,900
| +6% | +$79.7K | 0.01% | 449 |
|
|
2022
Q4 | $1.17M | Buy |
30,800
+2,100
| +7% | +$80.1K | 0.01% | 566 |
|
|
2022
Q3 | $1.12M | Buy |
+28,700
| New | +$1.12M | 0.01% | 539 |
|
|
2022
Q1 | $1.08M | Sell |
32,500
-3,400
| -9% | -$113K | 0.01% | 616 |
|
|
2021
Q4 | $1.53K | Sell |
35,900
-4,100
| -10% | -$174 | 0.01% | 513 |
|
|
2021
Q3 | $1.77M | Buy |
40,000
+1,200
| +3% | +$53.2K | 0.02% | 460 |
|
|
2021
Q2 | $2.2M | Buy |
38,800
+24,800
| +177% | +$1.41M | 0.02% | 424 |
|
|
2021
Q1 | $1.05M | Buy |
14,000
+7,800
| +126% | +$584K | 0.01% | 644 |
|
|
2020
Q4 | $536K | Sell |
6,200
-2,300
| -27% | -$199K | 0.01% | 819 |
|
|
2020
Q3 | $520K | Sell |
8,500
-2,000
| -19% | -$122K | 0.01% | 752 |
|
|
2020
Q2 | $437K | Buy |
10,500
+2,800
| +36% | +$117K | 0.01% | 847 |
|
|
2020
Q1 | $221K | Buy |
7,700
+300
| +4% | +$8.61K | ﹤0.01% | 1001 |
|
|
2019
Q4 | $534K | Buy |
7,400
+1,800
| +32% | +$130K | 0.01% | 908 |
|
|
2019
Q3 | $786K | Buy |
5,600
+1,600
| +40% | +$225K | 0.01% | 772 |
|
|
2019
Q2 | $732K | Sell |
4,000
-400
| -9% | -$73.2K | 0.01% | 789 |
|
|
2019
Q1 | $700K | Buy |
4,400
+1,700
| +63% | +$270K | 0.01% | 799 |
|
|
2018
Q4 | $259K | Buy |
+2,700
| New | +$259K | ﹤0.01% | 1014 |
|